Visceral Medicine

Visceral Medicine is a peer-reviewed journal about diseases of the abdominal organs, edited where gastrointestinal medicine meets operative practice.《内脏医学》是一本同行评审期刊，讨论腹部器官疾病，编辑视角落在胃肠内科与手术治疗的交汇处。

Clarivate's 2025 file gives it a Journal Impact Factor of 1.9, a five-year figure of 2.4, a Journal Citation Indicator of 0.44 and a place in the second quartile of Surgery.Clarivate 2025 年档案给出影响因子 1.9、五年影响因子 2.4、期刊引文指标 0.44，并在外科类别列入第二区。

That same file counts 1,058 citations, thirteen articles and a cited half-life of 5.8 years, while the Gastroenterology and Hepatology category places the title in the third quartile.同一份档案记入总被引 1058 次、年发文 13 篇、被引半衰期 5.8 年，而胃肠病学与肝病学类别把它放在第三区。

Scope

• Coverage begins with the oesophagus and stomach and runs through the small bowel, colon and rectum, so that benign and malignant disease of the digestive tract sit in one editorial frame.覆盖范围从食管与胃延伸到小肠、结肠与直肠，消化道良性与恶性疾病因此落在同一个编辑框架内。
• Diseases of the liver, biliary tree and pancreas form a second core, from gallstone disease and chronic hepatitis to pancreatic cystic lesions and carcinoma.肝、胆道与胰腺疾病构成第二块核心，从胆石病、慢性肝炎一直到胰腺囊性病变与胰腺癌。
• Surgical oncology is treated alongside medical oncology, with resection technique, neoadjuvant regimens and palliative pathways read as parts of one treatment sequence.外科肿瘤学与内科肿瘤学并列处理，切除技术、新辅助方案与姑息路径被放在同一条治疗序列中阅读。
• Diagnostic and therapeutic endoscopy recurs throughout, including submucosal dissection, full-thickness resection and third-space procedures.诊断性与治疗性内镜贯穿全刊，黏膜下剥离、全层切除与第三空间操作都在其中。
• Minimally invasive and robotic approaches to colorectal and upper gastrointestinal disease are followed closely, with conversion rates and learning curves brought into the discussion.结直肠与上消化道疾病的微创及机器人入路受到持续关注，中转率与学习曲线也被纳入讨论。
• Complications after abdominal operations receive regular space, and the fourth issue of volume 41 gathered papers on anastomotic leakage, biliary leaks and perforation handled endoscopically.腹部手术后的并发症有固定篇幅，第 41 卷第 4 期集中刊出吻合口漏、胆漏与穿孔的内镜处理文章。
• Inflammatory bowel disease appears through reviews on colitis-associated dysplasia and on targeted therapy for ulcerative colitis and Crohn's disease.炎症性肠病以综述形式出现，涉及结肠炎相关异型增生，以及溃疡性结肠炎与克罗恩病的靶向治疗。
• Early detection of pancreatic cancer formed the theme of volume 41 issue 5, covering biomarkers, sectional imaging and the surgical management of early-stage tumours.胰腺癌早期发现构成第 41 卷第 5 期的主题，涵盖生物标志物、断层影像与早期肿瘤的手术处理。
• Parasitic and rare abdominal infections are not excluded, and volume 41 issue 6 was given over to cystic and alveolar echinococcosis.寄生虫病与少见腹部感染同样在列，第 41 卷第 6 期整期讨论囊型与泡型棘球蚴病。
• Transplantation, perioperative care and metabolic surgery round out the clinical side, while registry studies supply outcome data drawn from German centres.移植、围手术期管理与代谢外科补足临床一侧，登记研究则提供来自德国各中心的结果数据。
• Interventional radiology and cross-sectional imaging appear where they change a surgical decision, as in the work on echinococcal lesions of the liver.介入放射与断层影像在能改变外科决策的地方出现，肝棘球蚴病变的处理即为一例。
• Guidelines, congress reports and continuing education belong to the remit, which keeps the title useful to clinicians who treat abdominal disease week by week.指南、会议报道与继续教育同属办刊范围，这使刊物对每周处理腹部疾病的临床医生保持实用。
• Abdominal problems in pregnancy have drawn a run of papers, among them appendicitis, proctological conditions and upper gastrointestinal tumours in pregnant patients.妊娠期的腹部问题引来一批文章，其中涉及阑尾炎、肛门直肠疾病与孕妇的上消化道肿瘤。

History

• The volume count reaches back to 1985, the first volume of a title that Karger has published without a break since then.卷号可回溯到 1985 年，那是 Karger 连续出版该刊的第 1 卷。
• Volume 14 carried the 1998 papers, volume 25 the 2009 papers and volume 32 the 2016 papers, a sequence that fixes 1985 as the starting year.1998 年的论文编在第 14 卷，2009 年在第 25 卷，2016 年在第 32 卷，这条序列把起始年锁定在 1985 年。
• The journal began in 1985 as Chirurgische Gastroenterologie, and Karger carried that title to volume 24 in 2008 under ISSN 0177-9990, with the 1992 papers in volume 8 and the 2005 papers in volume 21.刊物 1985 年以《Chirurgische Gastroenterologie》之名创办，Karger 用 ISSN 0177-9990 一直出到 2008 年第 24 卷，1992 年的论文编在第 8 卷，2005 年在第 21 卷。
• The name became Viszeralmedizin with volume 25 in 2009, registered under ISSN 1662-6664 in print and 1662-6672 in electronic form.2009 年第 25 卷起改称《Viszeralmedizin》，印刷版 ISSN 1662-6664、电子版 ISSN 1662-6672。
• The German title reflected its origins in the German-speaking surgical and gastroenterological community, and German-language notices still appear in its pages.德文题名反映它出自德语区的外科与消化科群体，德文简讯至今仍见于刊内。
• Volume 31, dated 2015, was the last under the Viszeralmedizin title. The retitled journal opened with volume 32 in 2016 and took the ISSN pair 2297-4725 and 2297-475X.标为 2015 年的第 31 卷是《Viszeralmedizin》名下的最后一卷；改题后的刊物从 2016 年第 32 卷起步，启用 ISSN 2297-4725 与 2297-475X。
• In the late 1990s and through the 2000s four issues appeared each year, as the issue numbering of the 1998 to 2007 volumes shows.1990 年代末到 2000 年代每年出 4 期，1998 年至 2007 年各卷的期号可以印证。
• The switch to six issues a year came with volume 27 in 2011, and every completed volume since carries issues 1 through 6.改为每年 6 期发生在 2011 年第 27 卷，此后出满的各卷都齐备 1 至 6 期。
• PubMed indexing starts with volume 32 issue 1 of 2016, and full texts are deposited in PubMed Central.PubMed 收录自 2016 年第 32 卷第 1 期开始，全文同时存入 PubMed Central。
• Impact factors moved from 1.96 in 2021 to 2.186 in 2022, then to 1.8, 1.6 and 1.9 in the three following years.影响因子从 2021 年的 1.96 升到 2022 年的 2.186，随后三年依次为 1.8、1.6 与 1.9。
• Clarivate lists the title in two categories, Surgery at rank 145 of 321 and Gastroenterology and Hepatology at 110 of 153, with a 55th percentile in the former.Clarivate 把它列入两个类别，外科排名 145/321，胃肠病学与肝病学排名 110/153，前者百分位为 55。
• Gold open access accounts for 21.05 percent of output, with the remaining papers released under subscription, which makes the journal a hybrid title.金色开放获取论文占 21.05%，其余按订阅模式发布，这使它归入混合型期刊。
• Annual output is small, thirteen articles in the 2025 count, and the 1,058 citations behind the current impact factor accumulate over a cited half-life of 5.8 years.年发文量不大，2025 年计 13 篇；支撑当前影响因子的 1058 次被引在半衰期 5.8 年中缓慢累积。
• Congresses remain part of the journal's calendar, and volume 42 carried a report on the NEXT GEN Day held at Viszeralmedizin 2026.年会仍在刊物的日程里，第 42 卷刊出 Viszeralmedizin 2026 的 NEXT GEN Day 报道。
• Two numbers are occasionally bound together, as with issue 3-4 of volume 39 in 2023, which keeps the six-issue rhythm intact across a year.偶尔两期合刊，2023 年第 39 卷第 3-4 期即为一例，年度 6 期的节奏因此不变。

Editors

• Ernst Klar led the journal as Editor-in-Chief for well over two decades. His name appears on an editorial as early as 2002, and a Festschrift honoured him in 2018.Ernst Klar 以主编身份主持刊物二十余年，早在 2002 年就有他署名的社论，2018 年刊物还为他出过纪念专辑。
• He stepped down at the end of 2025. The handover piece, Passing on the Baton, ran in volume 42 issue 2 and was signed by three colleagues.他在 2025 年底卸任，交接文 Passing on the Baton 刊于第 42 卷第 2 期，由三位同事署名。
• Georg Kaehler works at the Medical Faculty Mannheim of Heidelberg University, and Markus F. Neurath at Erlangen University Hospital.Georg Kaehler 任职于海德堡大学曼海姆医学院，Markus F. Neurath 任职于埃尔朗根大学医院。
• Jens Werner, the third signatory, is based at the LMU hospital in Munich. The trio spans the operative and the medical branches of the field.第三位署名者 Jens Werner 在慕尼黑大学医院工作，三人分属外科与内科两个分支。
• Issues are built around a theme, and the papers inside a single issue are grouped by organ and by technique.各期围绕主题搭建，期内的文章按器官与技术分组。
• Volume 41 shows the pattern. Issue 4 dealt with endoscopic management of postsurgical complications, issue 5 with early pancreatic cancer and issue 6 with echinococcosis.第 41 卷可以看出这种安排，第 4 期谈术后并发症的内镜处理，第 5 期谈胰腺癌早诊，第 6 期谈棘球蚴病。
• Manuscripts are refereed externally, and the journal prints an annual acknowledgement naming the reviewers who worked on the previous volume.稿件经外部同行评审，刊物每年刊出致谢名单，列出为上一卷审稿的学者。
• Society bulletins appear in most issues, a standing slot that ties the editorial pages to the associations behind the field.学会简报出现在多数期号里，这个固定栏目把编辑版面与领域内的学会联系起来。
• English carries the scientific content. A pharma news section and some product notices remain in German, a residue of the bilingual past.学术内容以英文承载，药讯栏目与部分产品通告仍用德文，是双语历史的残留。
• Corrections are issued as separate items, as with the erratum in volume 42 issue 2, and congress reports sit beside the research papers.勘误单独成条刊出，第 42 卷第 2 期的勘误即为一例，会议报道则与研究论文并列。